Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2025-12-25 @ 12:13 PM
NCT ID: NCT02944461
Description: None
Frequency Threshold: 0
Time Frame: 16 weeks
Study: NCT02944461
Study Brief: Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dapsone Gel 7.5% Dapsone gel 7.5% to be applied to truncal acne once daily for 16 weeks. Dapsone 7.5 % gel: Dapsone gel 7.5% applied once daily to truncal acne 0 None 0 20 3 20 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
stye, right eye SYSTEMATIC_ASSESSMENT Eye disorders None View
sunburn arms/chest/back SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
infected abrasions of legs SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
gum graft surgery SYSTEMATIC_ASSESSMENT Surgical and medical procedures None View